Vanguard Group Inc Nektar Therapeutics Put Options Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding NKTR
# of Institutions
168Shares Held
123MCall Options Held
1.18MPut Options Held
64.6K-
Black Rock Inc. New York, NY15.2MShares$140 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT7.79MShares$72 Million0.24% of portfolio
-
Acadian Asset Management LLC Boston, MA7.3MShares$67.5 Million0.01% of portfolio
-
Eventide Asset Management, LLC Boston, MA6.65MShares$61.5 Million0.1% of portfolio
-
Primecap Management CO Pasadena, CA5.35MShares$49.5 Million0.0% of portfolio
About NEKTAR THERAPEUTICS
- Ticker NKTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,404,992
- Market Cap $1.73B
- Description
- Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...